Stay updated on Pembrolizumab in Pediatric Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Pediatric Solid Tumors Clinical Trial page.

Latest updates to the Pembrolizumab in Pediatric Solid Tumors Clinical Trial page
- Check5 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedEnrollment site update: Fargo, North Dakota (58102) was added as a current site, while the Fargo, North Dakota (58122) site was removed. The page revision has been updated to version 3.5.0.SummaryDifference0.2%

- Check48 days agoChange DetectedPage revision label updated from v3.4.2 to v3.4.3, indicating an internal update.SummaryDifference0.0%

- Check69 days agoChange DetectedRevision label on the page updated from v3.4.1 to v3.4.2, replacing the previous version.SummaryDifference0.0%

- Check77 days agoChange DetectedRevision: v3.4.1 was added and revision: v3.4.0 was removed. This appears to be a backend/UI version update with no visible changes to the study details.SummaryDifference0.0%

- Check98 days agoChange DetectedRevision metadata updated from v3.3.3 to v3.3.4. This appears to be a minor version update with no changes to the study content, eligibility criteria, or listed locations.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab in Pediatric Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Pediatric Solid Tumors Clinical Trial page.